Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.95M | -10.15M | -9.32M | -9.61M | -8.87M |
| Total Depreciation and Amortization | 377.90K | 350.40K | 359.20K | 370.50K | 326.70K |
| Total Amortization of Deferred Charges | -- | -- | 736.10K | 759.10K | -- |
| Total Other Non-Cash Items | 1.20M | 1.11M | -1.71M | -1.76M | 112.50K |
| Change in Net Operating Assets | -812.60K | -753.50K | 7.26M | 7.49M | -1.54M |
| Cash from Operations | -10.18M | -9.44M | -2.67M | -2.76M | -9.97M |
| Capital Expenditure | -158.30K | -146.80K | -566.00K | -583.80K | -1.08M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -178.20K | -165.20K | -372.00K | -383.70K | 300.30K |
| Cash from Investing | -336.50K | -312.00K | -938.10K | -967.50K | -778.20K |
| Total Debt Issued | 10.15M | 10.15M | -10.00M | -10.00M | 10.00M |
| Total Debt Repaid | -8.50K | -8.50K | -36.50K | -36.50K | -583.50K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -119.50K | -119.50K | 13.90M | 13.90M | 200.50K |
| Cash from Financing | 11.37M | 10.55M | 4.12M | 4.25M | 10.35M |
| Foreign Exchange rate Adjustments | -795.60K | -737.70K | 212.70K | 219.30K | 215.30K |
| Miscellaneous Cash Flow Adjustments | -600.00 | -500.00 | -- | -- | -- |
| Net Change in Cash | 57.90K | 53.70K | 719.50K | 742.10K | -186.20K |